Drug Abuse News and Research

RSS

Alcohol addiction drug may help opioid addicts: FDA panel considers reports

A U.S. Food and Drugs Administration (FDA) panel, this Thursday agreed that a new drug Vivitrol helps alcoholics and opioid addicts kick the habit. The panel voted 11 to 2 that there was sufficient evidence from a single clinical trial that Vivitrol is effective when it comes to helping people addicted to painkillers.

17 Sep 2010

Kings Cross drug injection center to become permanent fixture

After running for quite some time amidst intense debates, the New South Wales Government has announced plans to make the medically-supervised drug injecting centre at Kings Cross a permanent fixture. This unit has been functioning since 2001 and was still looking for permanency. A latest review of this trial center showed that it has successfully managed more than 3,000 overdoses and helped 12,000 drug users.

15 Sep 2010

Gladstone Institute elects for 2010 recipient of Avant-Garde Award for HIV/AIDS Research

The National Institute on Drug Abuse, part of the National Institutes of Health, announced today that Dr. Eric M. Verdin of the J. David Gladstone Institutes in San Francisco, Calif., has been selected as the 2010 recipient of the NIDA Avant-Garde Award for HIV/AIDS Research for his proposal to study the mechanisms of latent HIV infection.

14 Sep 2010

Alice Cepeda receives National Award of Excellence in Research for Hispanic drug abuse research

The National Hispanic Science Network on Drug Abuse awarded the National Award of Excellence in Research by a New Investigator to Alice Cepeda, sociology professor and associate director of the Center for Drug and Social Policy Research, Graduate College of Social Work, University of Houston. Cepeda will be honored Sept. 30 at the organization's annual conference in New Orleans.

14 Sep 2010

NAADAC and Hazelden partner to improve treatment for co-occurring disorders

NAADAC, the Association for Addiction Professionals, and Hazelden, the national nonprofit focused on addiction treatment, prevention and recovery announced today a new strategic partnership focused on improving the treatment of co-occurring disorders. The partnership announcement was made by NAADAC Executive Director Cynthia Moreno Tuohy during the National Conference on Addiction Disorders in Washington, D.C.

10 Sep 2010

Nation's four leading ADHD organizations seek to end persistent myths about ADHD

Four national organizations – ADHD Coaches Organization; Attention Deficit Disorder Association; ADDitude magazine; and Children and Adults with Attention-Deficit/Hyperactivity Disorder – are issuing a joint call to the public to assist children, adults, and families who are affected by ADHD.

9 Sep 2010

UCLA psychologist explains measure to overcome drug addiction

Millions of Americans suffer from severe addictions that can ruin lives and are extremely difficult to control. Nearly 2 million enter roughly 12,000 addiction treatment programs in the U.S. each year.

9 Sep 2010

Cocaine use on the rise in Australia

The number of cocaine abuse related arrests has risen in Sydney's CBD and an increasing number of users of the drug are being treated in hospitals. According to the latest NSW Bureau of Crime Statistics and Research figures arrests for possession and use of the drug have risen by 76.6 per cent in the past two years.

8 Sep 2010

NIH announces $161.3 million for expansion of Pharmacogenomics Research Network

The National Institutes of Health plans to spend $161.3 million over the next five years to expand the Pharmacogenomics Research Network (PGRN), a nationwide collaborative of scientists focused on understanding how genes affect a person's response to medicines.

8 Sep 2010

NIH awards St. Jude $8.6M to focus on anticancer agent research in children

With its new expansion of the Pharmacogenomics Research Network (PGRN), the National Institutes of Health (NIH) awarded St. Jude Children's Research Hospital a prestigious grant to focus on anticancer agent research in children.

8 Sep 2010

Penn receives $12M NIH grant to study pharmacogenetics of nicotine addiction treatment

A variety of smoking cessation treatments are currently available for the more than 18 million adult Americans try to quit smoking each year, but success rates vary widely. Despite the importance of quitting smoking, more personalized approaches to smoking cessation treatment are needed to help smokers pick the right method that will work best for them. A major new personalized medicine clinical trial, led by addiction researchers at the University of Pennsylvania, will study how a smokers' genetic make-up influences their quitting success.

8 Sep 2010

Methylphenidate facilitates recovery from drug addiction

A brain-scanning study at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory, conducted with collaborators from Stony Brook University, reveals that an oral dose of methylphenidate, commonly known as Ritalin, improves impaired brain function and enhances cognitive performance in people who are addicted to cocaine.

7 Sep 2010

Young drug users develop brain abnormalities

According to a new study published in the Australian Medical Journal, 20 percent of users of the drugs ecstasy, ice and speed in the ER developed signs of brain damage. Two thirds had concentration and mood problems, and half said they had general health problems.

5 Sep 2010

Kavli Day 2010 at Norwegian University of Science and Technology

In celebration of Kavli Prize Week, the Norwegian University of Science and Technology (NTNU), the Norwegian Academy of Science and Letters, and the Kavli Foundation will hold a series of lectures and events on 9 September 2010 in Trondheim, Norway at the NTNU campus. The event features a number of 2010 Kavli Prize Laureates. The festivities continue after the official celebration, with two symposia sponsored by NTNU, one in neuroscience and one in nanoscience.

4 Sep 2010

'Gateway effect' of marijuana overblown

New research from the University of New Hampshire shows that the "gateway effect" of marijuana - that teenagers who use marijuana are more likely to move on to harder illicit drugs as young adults - is overblown.

3 Sep 2010

World becoming numb to HIV/AIDS: UNAIDS executive director

HIV infection is on the rise but there is potential to control the upsurge of infections with effective measures only if there are adequate funds. According to UNAIDS executive director Michel Sidibe the world has become numb to the fact that 7,400 people are being infected with AIDS every day and funds to combat it are not pouring in as they should. Since 2001, the number of newly infected people has fallen by 17 per cent a year - but there are still 2.7 million new cases each year.

1 Sep 2010

Study finds common risk factors linked with painkiller addiction

A new Geisinger study begins to unlock the puzzle of painkiller (opioid) addiction - why some people are more likely to become addicted than others. Geisinger investigators have found that patients with four common risk factors have a significantly higher risk of addiction. In addition, a history of severe drug dependence and drug abuse compounds the risk.

30 Aug 2010

New alchemy module allows healthcare providers to verify, comply with state and federal prescription drug regulations

Gold Standard/Elsevier, developer of drug databases and medication management solutions, announced today the availability of its new Alchemy.

27 Aug 2010

Today's Opinions: Sebelius on EMRs, primary care's role in reform and more

Health care providers may agree with the benefits of electronic health records. But they also believed that adopting them was too difficult and expensive. … [T]hat's changing - in large part due to an ambitious investment we made in the Recovery Act to reduce many of the obstacles that limited the spread of electronic health records in the past (HHS Secretary Kathleen Sebelius, 8/26).

27 Aug 2010

Disulfiram drug effective in treating cocaine addiction: Research

Doctors have used the drug disulfiram to help patients stay sober for several decades. It interferes with the body's ability to metabolize alcohol, giving a fierce hangover to someone who consumes even a small amount of alcohol.More recently, disulfiram was shown to be effective in treating cocaine addiction as well, even though alcohol and cocaine affect the nervous system in different ways.

27 Aug 2010